The Food And Drug Administration (fda) - Cancer Science

Relevant Publications

Accuracy of reported energy in food and beverages supplied to hospital patients.

Issue Release: 2025

Implications of An Evolving Regulatory Landscape on the Development of AI and ML in Medicine.

Issue Release: 2025

Quantification of treprostinil concentration in rat and human using a novel validated and rapid liquid chromatography-tandem mass spectrometry method: Experimental and clinical applications in ischemia-reperfusion injury.

Issue Release: 2024

Inflammatory myofibroblastic tumor from molecular diagnostics to current treatment.

Issue Release: 2024

Anti-amyloid-β Antibodies and Anti-tau Therapies for Alzheimer\'s Disease: Recent Advances and Perspectives.

Issue Release: 2024

Cancer treatment with biosimilar drugs: A review.

Issue Release: 2024

Differences Between the 2016 and 2022 Food and Drug Administration Guidance-Implications for Design and Interpretation of Clinical Trials in Ulcerative Colitis.

Issue Release: 2024

Determination of procoagulant activity in human normal immunoglobulin preparations for therapeutic use by FXIa chromogenic assay: Evaluation of test kit sensitivity, reference standard performance and product formulation effects on the FXIa assay.

Issue Release: 2024

A CD36-dependent non-canonical lipid metabolism program promotes immune escape and resistance to hypomethylating agent therapy in AML.

Issue Release: 2024

Poly (ADP-ribose) polymerase (PARP) inhibitors as anticancer agents: An outlook on clinical progress, synthetic strategies, biological activity, and structure-activity relationship.

Issue Release: 2024

Overdosage Section in US and EU Labeling.

Issue Release: 2024

Semaglutide and health risk: Development and validation of a LC-HRMS method for testing semaglutide in whole blood and application to real cases.

Issue Release: 2024

Metformin drugs under simulated gastric conditions can generate high nitrite-dependent levels of N-nitrosodimethylamine.

Issue Release: 2024

Novel selective inhibitors of macropinocytosis-dependent growth in pancreatic ductal carcinoma.

Issue Release: 2024

Multifaceted role of erlotinib in various cancer: nanotechnology intervention, patent landscape, and advancements in clinical trials.

Issue Release: 2024

SENP2-NDR2-p21 Axis Modulates Lung Cancer Cell Growth.

Issue Release: 2024

Qualitative Analysis of Inquiries Received by FDA Regarding Conduct of Clinical Trials during the Covid-19 Public Health Emergency.

Issue Release: 2024

Pathology of acute sub-lethal or near-lethal irradiation of nonhuman primates prophylaxed with the nutraceutical, gamma tocotrienol.

Issue Release: 2024

(Homo-)harringtonine prevents endothelial inflammation through IRF-1 dependent downregulation of VCAM1 mRNA expression and inhibition of cell adhesion molecule protein biosynthesis.

Issue Release: 2024

Suboptimal bioinformatic predictions of antimicrobial resistance from whole-genome sequences in multidrug-resistant Corynebacterium isolates.

Issue Release: 2024

How Does Machine Learning Benefit from Scalable Architecture?

Can Nuclear Receptors Predict Cancer Prognosis?

What Resources are Available for Psychological Support?

How Does One Apply for Expanded Access?

What are the Treatment Options for Brain Cancer?

How Does Acrylamide Affect Human Health?

Why is Rapid Dissemination Dangerous?

What are the Current Therapeutic Approaches for KRAS-Mutated Cancers?

How to Prepare for HDR Brachytherapy?

What Are the Advantages of MSP?

The Food And Drug Administration (fda) - Cancer Science

Relevant Publications

Partnered Content Networks

Relevant Topics